v3.25.4
ENTITY WIDE DISCLOSURES - Summary of Revenue by Major Source (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Disaggregation Of Revenue [Line Items]      
Total revenue $ 2,530,234 $ 2,109,054 $ 1,885,842
Oncology      
Disaggregation Of Revenue [Line Items]      
Total revenue 747,585 651,237 587,097
Metabolic      
Disaggregation Of Revenue [Line Items]      
Total revenue 408,548 431,384 404,844
Other      
Disaggregation Of Revenue [Line Items]      
Total revenue 744,957 457,542 376,842
Central Nervous System      
Disaggregation Of Revenue [Line Items]      
Total revenue 239,371 230,454 193,690
Cardiology      
Disaggregation Of Revenue [Line Items]      
Total revenue 134,935 156,460 163,312
AVAI      
Disaggregation Of Revenue [Line Items]      
Total revenue $ 254,838 $ 181,977 $ 160,057